Endocarditis on Hemodialysis: Link Bloodstream and Access

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.

Endocarditis on Hemodialysis: Link Bloodstream and Access: six-panel learning summary. Full text follows below.
Download infographic (PNG) · Download Markdown · Read text version ·

Text version

High exposure, high stakes

Repeated vascular access and bloodstream infection risk make endocarditis an important consideration in dialysis patients with persistent bacteremia or systemic illness.

Look for more than fever

Embolic signs, new cardiac findings, access abnormalities, persistent positive cultures, and unexplained deterioration can reveal a deeper infection.

Define the organism and source

Blood cultures, appropriate echocardiography, access assessment, and susceptibility testing guide diagnosis and treatment. Prior antibiotics can complicate interpretation.

Coordinate treatment

Coordinate infectious disease, nephrology, cardiology, and surgery. Choose susceptibility-directed treatment and dialysis-adjusted exposure; intermittent dialysis-day-only regimens are not established replacements for standard therapy.

Do not ignore source control

An infected catheter, persistent bacteremia, valve complications, or metastatic infection may prevent cure despite an apparently appropriate antibiotic.

Follow for relapse and harm

Monitor cultures, clinical response, drug-related adverse effects, and access planning. Treatment success requires resolution of the infection pathway.

Continue learning

This graphic summarizes a topic. The full educational pages provide the broader discussion and references.

Selected evidence